Oncogene - Table of Contents alert Volume 33 Issue 8

If you are unable to see the message below, click here to view.

Advertisement BLUEPRINT quality antibodies you can TRUST. Partnering with epigenetics experts in the BLUEPRINT Epigenome consortium, Diagenode has developed completely validated epigenetics antibodies with the highest specificity and sensitivity available. Achieve unparalleled MeDIP, ChIP, and ChIP-seq results with validated antibodies you can trust. Learn more. TABLE OF CONTENTS Volume 33, Issue 8 (February 2014) In this issue Review Commentary Original Articles Short Communication Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement The new Cancer Gene Therapy CGT has a new editor in chief with a new vision for the journal: Steven K. Libutti, M.D. - Director of Montefiore-Einstein Center for Cancer Care - Associate Director for Clinical Services, Albert Einstein Cancer Center.  Submit your research and be a part of the new Cancer Gene Therapy. You can follow CGT on Twitter @cgtnature Review Top The regulatory roles of phosphatases in cancer J Stebbing, L C Lit, H Zhang, R S Darrington, O Melaiu, B Rudraraju and G Giamas Oncogene 2014 33: 939-953; advance online publication, March 18, 2013; 10.1038/onc.2013.80 Abstract | Full Text Commentary Top To be or not to be a proliferation marker? J M Blanchard Oncogene 2014 33: 954-955; advance online publication, February 11, 2013; 10.1038/onc.2013.19 Abstract | Full Text Original Articles Top Knockdown of Slingshot 2 (SSH2) serine phosphatase induces Caspase3 activation in human carcinoma cell lines with the loss of the Birt–Hogg–Dubé tumour suppressor gene (FLCN) X Lu, U Boora, L Seabra, E M Rabai, J Fenton, A Reiman, Z Nagy and E R Maher Oncogene 2014 33: 956-965; advance online publication, February 18, 2013; 10.1038/onc.2013.27 Abstract | Full Text Identification of novel determinants of resistance to lapatinib in ERBB2-amplified cancers D Wetterskog, K-K Shiu, I Chong, T Meijer, A Mackay, M Lambros, D Cunningham, J S Reis-Filho, C J Lord and A Ashworth Oncogene 2014 33: 966-976; advance online publication, March 11, 2013; 10.1038/onc.2013.41 Abstract | Full Text Constitutively active TrkB confers an aggressive transformed phenotype to a neural crest-derived cell line J DeWitt, V Ochoa, J Urschitz, M Elston, S Moisyadi and R Nishi Oncogene 2014 33: 977-985; advance online publication, March 4, 2013; 10.1038/onc.2013.39 Abstract | Full Text Engineering a single ubiquitin ligase for the selective degradation of all activated ErbB receptor tyrosine kinases F Kong, J Zhang, Y Li, X Hao, X Ren, H Li and P Zhou Oncogene 2014 33: 986-995; advance online publication, February 18, 2013; 10.1038/onc.2013.33 Abstract | Full Text NF-κB1 p50 promotes p53 protein translation through miR-190 downregulation of PHLPP1 Y Yu, D Zhang, H Huang, J Li, M Zhang, Y Wan, J Gao and C Huang Oncogene 2014 33: 996-1005; advance online publication, February 11, 2013; 10.1038/onc.2013.8 Abstract | Full Text CD84 is a survival receptor for CLL cells I Binsky-Ehrenreich, A Marom, M C Sobotta, L Shvidel, A Berrebi, I Hazan-Halevy, S Kay, A Aloshin, I Sagi, D M Goldenberg, L Leng, R Bucala, Y Herishanu, M Haran and I Shachar Oncogene 2014 33: 1006-1016; advance online publication, February 25, 2013; 10.1038/onc.2013.31 Abstract | Full Text HOXA1 drives melanoma tumor growth and metastasis and elicits an invasion gene expression signature that prognosticates clinical outcome J Wardwell-Ozgo, T Dogruluk, A Gifford, Y Zhang, T P Heffernan, R van Doorn, C J Creighton, L Chin and K L Scott Oncogene 2014 33: 1017-1026; advance online publication, February 25, 2013; 10.1038/onc.2013.30 Abstract | Full Text Sensitisation of c-MYC-induced B-lymphoma cells to apoptosis by ATF2 J Walczynski, S Lyons, N Jones and W Breitwieser Oncogene 2014 33: 1027-1036; advance online publication, February 18, 2013; 10.1038/onc.2013.28 Abstract | Full Text Targeting HPV16 E6-p300 interaction reactivates p53 and inhibits the tumorigenicity of HPV-positive head and neck squamous cell carcinoma X Xie, L Piao, B N Bullock, A Smith, T Su, M Zhang, T N Teknos, P S Arora and Q Pan Oncogene 2014 33: 1037-1046; advance online publication, March 11, 2013; 10.1038/onc.2013.25 Abstract | Full Text PTPN12 promotes resistance to oxidative stress and supports tumorigenesis by regulating FOXO signaling I S Harris, H Blaser, J Moreno, A E Treloar, C Gorrini, M Sasaki, J M Mason, C B Knobbe, A Rufini, M Hallé, A J Elia, A Wakeham, M L Tremblay, G Melino, S Done and T W Mak Oncogene 2014 33: 1047-1054; advance online publication, February 25, 2013; 10.1038/onc.2013.24 Abstract | Full Text K63-Ubiquitylation of VHL by SOCS1 mediates DNA double-strand break repair J L Metcalf, P S Bradshaw, M Komosa, S N Greer, M Stephen Meyn and M Ohh Oncogene 2014 33: 1055-1065; advance online publication, March 4, 2013; 10.1038/onc.2013.22 Abstract | Full Text Short Communication Top MYC activity is negatively regulated by a C-terminal lysine cluster A R Wasylishen, M Kalkat, S S Kim, A Pandyra, P-K Chan, S Oliveri, E Sedivy, D Konforte, C Bros, B Raught and L Z Penn Oncogene 2014 33: 1066-1072; advance online publication, February 25, 2013; 10.1038/onc.2013.36 Abstract | Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2014 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.